Paraguay

Paraguay

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.99 (2.44 - 3.54) 2019 Modelled IHME
3 (2.47 - 3.54) 2018 Modelled IHME
3.03 (2.49 - 3.61) 2017 Modelled IHME
3.09 (2.55 - 3.71) 2016 Modelled IHME
3.18 (2.58 - 3.78) 2015 Modelled IHME
3.25 (2.64 - 3.85) 2014 Modelled IHME
3.33 (2.70 - 3.95) 2013 Modelled IHME
3.39 (2.74 - 4.06) 2012 Modelled IHME
3.45 (2.78 - 4.13) 2011 Modelled IHME
3.49 (2.80 - 4.18) 2010 Modelled IHME
3.51 (2.85 - 4.16) 2009 Modelled IHME
3.52 (2.87 - 4.17) 2008 Modelled IHME
3.54 (2.88 - 4.18) 2007 Modelled IHME
3.55 (2.88 - 4.22) 2006 Modelled IHME
3.57 (2.88 - 4.27) 2005 Modelled IHME
3.61 (2.94 - 4.31) 2004 Modelled IHME
3.66 (2.98 - 4.38) 2003 Modelled IHME
3.71 (3.04 - 4.45) 2002 Modelled IHME
3.76 (3.08 - 4.54) 2001 Modelled IHME
3.79 (3.09 - 4.59) 2000 Modelled IHME
3.8 (3.10 - 4.57) 1999 Modelled IHME
3.82 (3.12 - 4.57) 1998 Modelled IHME
3.83 (3.12 - 4.55) 1997 Modelled IHME
3.84 (3.11 - 4.54) 1996 Modelled IHME
3.84 (3.08 - 4.57) 1995 Modelled IHME
3.83 (3.11 - 4.54) 1994 Modelled IHME
3.82 (3.10 - 4.51) 1993 Modelled IHME
3.8 (3.08 - 4.48) 1992 Modelled IHME
3.78 (2.99 - 4.49) 1991 Modelled IHME
3.75 (2.92 - 4.52) 1990 Modelled IHME
1.75 (0.13 - 20.61) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.14 (0.10 - 0.19) 2019 Modelled IHME
0.14 (0.10 - 0.19) 2018 Modelled IHME
0.14 (0.11 - 0.19) 2017 Modelled IHME
0.15 (0.11 - 0.20) 2016 Modelled IHME
0.17 (0.12 - 0.23) 2015 Modelled IHME
0.19 (0.14 - 0.26) 2014 Modelled IHME
0.22 (0.16 - 0.29) 2013 Modelled IHME
0.25 (0.18 - 0.33) 2012 Modelled IHME
0.27 (0.20 - 0.36) 2011 Modelled IHME
0.28 (0.20 - 0.37) 2010 Modelled IHME
0.28 (0.20 - 0.37) 2009 Modelled IHME
0.28 (0.21 - 0.37) 2008 Modelled IHME
0.28 (0.21 - 0.38) 2007 Modelled IHME
0.29 (0.20 - 0.38) 2006 Modelled IHME
0.29 (0.20 - 0.38) 2005 Modelled IHME
0.45 (0.32 - 0.61) 2004 Modelled IHME
0.84 (0.60 - 1.15) 2003 Modelled IHME
1.31 (0.93 - 1.78) 2002 Modelled IHME
1.71 (1.21 - 2.32) 2001 Modelled IHME
1.89 (1.34 - 2.61) 2000 Modelled IHME
1.92 (1.37 - 2.58) 1999 Modelled IHME
1.94 (1.39 - 2.60) 1998 Modelled IHME
1.95 (1.40 - 2.61) 1997 Modelled IHME
1.96 (1.40 - 2.62) 1996 Modelled IHME
1.96 (1.40 - 2.65) 1995 Modelled IHME
1.96 (1.40 - 2.62) 1994 Modelled IHME
1.95 (1.41 - 2.58) 1993 Modelled IHME
1.94 (1.40 - 2.56) 1992 Modelled IHME
1.93 (1.37 - 2.54) 1991 Modelled IHME
1.91 (1.35 - 2.56) 1990 Modelled IHME
0.65 (0.05 - 8.94) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.71 (1.14 - 2.45) 2019 Modelled IHME
1.69 (1.16 - 2.39) 2018 Modelled IHME
1.69 (1.19 - 2.35) 2017 Modelled IHME
1.68 (1.22 - 2.29) 2016 Modelled IHME
1.62 (1.18 - 2.21) 2015 Modelled IHME
1.67 (1.23 - 2.25) 2014 Modelled IHME
1.88 (1.39 - 2.53) 2013 Modelled IHME
2.08 (1.56 - 2.76) 2012 Modelled IHME
2.27 (1.69 - 3) 2011 Modelled IHME
2.36 (1.77 - 3.10) 2010 Modelled IHME
2.31 (1.74 - 3.02) 2009 Modelled IHME
2.18 (1.63 - 2.87) 2008 Modelled IHME
2.1 (1.60 - 2.72) 2007 Modelled IHME
2.06 (1.55 - 2.65) 2006 Modelled IHME
1.99 (1.52 - 2.55) 2005 Modelled IHME
1.97 (1.51 - 2.57) 2004 Modelled IHME
1.92 (1.46 - 2.49) 2003 Modelled IHME
1.9 (1.42 - 2.48) 2002 Modelled IHME
1.93 (1.43 - 2.48) 2001 Modelled IHME
1.97 (1.47 - 2.53) 2000 Modelled IHME
1.99 (1.50 - 2.56) 1999 Modelled IHME
1.96 (1.48 - 2.53) 1998 Modelled IHME
1.92 (1.44 - 2.45) 1997 Modelled IHME
1.94 (1.49 - 2.47) 1996 Modelled IHME
1.92 (1.48 - 2.43) 1995 Modelled IHME
1.91 (1.44 - 2.46) 1994 Modelled IHME
1.88 (1.36 - 2.46) 1993 Modelled IHME
1.85 (1.36 - 2.43) 1992 Modelled IHME
1.77 (1.30 - 2.31) 1991 Modelled IHME
1.81 (1.36 - 2.33) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
118 (79 - 170) 2019 Modelled IHME
116 (80 - 164) 2018 Modelled IHME
114 (80 - 159) 2017 Modelled IHME
112 (82 - 152) 2016 Modelled IHME
106 (77 - 145) 2015 Modelled IHME
108 (79 - 146) 2014 Modelled IHME
120 (88 - 162) 2013 Modelled IHME
131 (98 - 173) 2012 Modelled IHME
141 (105 - 186) 2011 Modelled IHME
144 (108 - 189) 2010 Modelled IHME
138 (104 - 181) 2009 Modelled IHME
129 (96 - 169) 2008 Modelled IHME
122 (93 - 158) 2007 Modelled IHME
117 (89 - 151) 2006 Modelled IHME
112 (85 - 143) 2005 Modelled IHME
109 (84 - 142) 2004 Modelled IHME
104 (79 - 135) 2003 Modelled IHME
101 (76 - 132) 2002 Modelled IHME
101 (75 - 130) 2001 Modelled IHME
101 (75 - 130) 2000 Modelled IHME
100 (75 - 128) 1999 Modelled IHME
96 (73 - 124) 1998 Modelled IHME
93 (69 - 118) 1997 Modelled IHME
92 (70 - 117) 1996 Modelled IHME
89 (68 - 112) 1995 Modelled IHME
86 (65 - 111) 1994 Modelled IHME
82 (60 - 108) 1993 Modelled IHME
79 (58 - 104) 1992 Modelled IHME
74 (54 - 96) 1991 Modelled IHME
73 (55 - 94) 1990 Modelled IHME
347 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
18 (12 - 24) 2019 Modelled IHME
18 (12 - 25) 2018 Modelled IHME
18 (12 - 24) 2017 Modelled IHME
18 (12 - 24) 2016 Modelled IHME
18 (12 - 24) 2015 Modelled IHME
18 (12 - 25) 2014 Modelled IHME
18 (13 - 25) 2013 Modelled IHME
18 (13 - 25) 2012 Modelled IHME
19 (13 - 26) 2011 Modelled IHME
19 (13 - 26) 2010 Modelled IHME
19 (13 - 26) 2009 Modelled IHME
19 (13 - 26) 2008 Modelled IHME
18 (13 - 25) 2007 Modelled IHME
18 (13 - 25) 2006 Modelled IHME
18 (13 - 25) 2005 Modelled IHME
18 (13 - 24) 2004 Modelled IHME
18 (13 - 24) 2003 Modelled IHME
18 (13 - 24) 2002 Modelled IHME
17 (13 - 24) 2001 Modelled IHME
17 (12 - 24) 2000 Modelled IHME
17 (13 - 24) 1999 Modelled IHME
17 (12 - 24) 1998 Modelled IHME
17 (12 - 24) 1997 Modelled IHME
17 (12 - 24) 1996 Modelled IHME
17 (12 - 24) 1995 Modelled IHME
17 (12 - 24) 1994 Modelled IHME
17 (12 - 24) 1993 Modelled IHME
17 (12 - 23) 1992 Modelled IHME
17 (12 - 23) 1991 Modelled IHME
17 (12 - 23) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
88 2018 Survey/reported WHO/UNICEF
91 2017 Survey/reported WHO/UNICEF
92 2016 Survey/reported WHO/UNICEF
92 2015 Survey/reported WHO/UNICEF
93 2014 Survey/reported WHO/UNICEF
90 2013 Survey/reported WHO/UNICEF
91 2012 Survey/reported WHO/UNICEF
91 2011 Survey/reported WHO/UNICEF
91 2010 Survey/reported WHO/UNICEF
85 2009 Survey/reported WHO/UNICEF
87 2008 Survey/reported WHO/UNICEF
86 2007 Survey/reported WHO/UNICEF
92 2006 Survey/reported WHO/UNICEF
92 2005 Survey/reported WHO/UNICEF
90 2004 Survey/reported WHO/UNICEF
86 2003 Survey/reported WHO/UNICEF
Showing out of
Show more

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HBV testing policy
Pregnant women
Source:
HepB birth dose policy
Yes
Source:
Year of birth dose introduction
2017
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.87 (1.50 - 2.34) 2019 Modelled IHME
1.85 (1.49 - 2.32) 2018 Modelled IHME
1.83 (1.47 - 2.29) 2017 Modelled IHME
1.82 (1.47 - 2.25) 2016 Modelled IHME
1.8 (1.45 - 2.22) 2015 Modelled IHME
1.79 (1.44 - 2.22) 2014 Modelled IHME
1.78 (1.44 - 2.20) 2013 Modelled IHME
1.76 (1.43 - 2.19) 2012 Modelled IHME
1.75 (1.41 - 2.19) 2011 Modelled IHME
1.73 (1.39 - 2.17) 2010 Modelled IHME
1.71 (1.38 - 2.15) 2009 Modelled IHME
1.68 (1.35 - 2.12) 2008 Modelled IHME
1.65 (1.33 - 2.08) 2007 Modelled IHME
1.63 (1.31 - 2.04) 2006 Modelled IHME
1.62 (1.30 - 2.02) 2005 Modelled IHME
1.62 (1.31 - 2.03) 2004 Modelled IHME
1.62 (1.31 - 2.04) 2003 Modelled IHME
1.62 (1.30 - 2.04) 2002 Modelled IHME
1.62 (1.31 - 2.04) 2001 Modelled IHME
1.63 (1.31 - 2.04) 2000 Modelled IHME
1.63 (1.31 - 2.04) 1999 Modelled IHME
1.63 (1.31 - 2.05) 1998 Modelled IHME
1.63 (1.31 - 2.06) 1997 Modelled IHME
1.64 (1.32 - 2.07) 1996 Modelled IHME
1.64 (1.31 - 2.07) 1995 Modelled IHME
1.64 (1.32 - 2.07) 1994 Modelled IHME
1.64 (1.32 - 2.07) 1993 Modelled IHME
1.65 (1.32 - 2.06) 1992 Modelled IHME
1.65 (1.32 - 2.06) 1991 Modelled IHME
1.65 (1.32 - 2.08) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
9.8 (7.70 - 11.90) 2006 Survey/reported UNAIDS, PAHO, UNCIEF, 2009

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.87 (1.98 - 4.03) 2019 Modelled IHME
2.85 (2.03 - 3.96) 2018 Modelled IHME
2.83 (2.07 - 3.82) 2017 Modelled IHME
2.81 (2.14 - 3.72) 2016 Modelled IHME
2.68 (2.08 - 3.52) 2015 Modelled IHME
2.57 (2 - 3.31) 2014 Modelled IHME
2.5 (1.94 - 3.21) 2013 Modelled IHME
2.37 (1.87 - 3.02) 2012 Modelled IHME
2.3 (1.80 - 2.97) 2011 Modelled IHME
2.27 (1.79 - 2.92) 2010 Modelled IHME
2.2 (1.74 - 2.83) 2009 Modelled IHME
2.09 (1.66 - 2.67) 2008 Modelled IHME
2.02 (1.59 - 2.55) 2007 Modelled IHME
1.99 (1.57 - 2.53) 2006 Modelled IHME
1.93 (1.51 - 2.44) 2005 Modelled IHME
1.9 (1.49 - 2.42) 2004 Modelled IHME
1.84 (1.44 - 2.31) 2003 Modelled IHME
1.81 (1.43 - 2.27) 2002 Modelled IHME
1.83 (1.45 - 2.32) 2001 Modelled IHME
1.86 (1.48 - 2.33) 2000 Modelled IHME
1.89 (1.49 - 2.39) 1999 Modelled IHME
1.88 (1.50 - 2.38) 1998 Modelled IHME
1.88 (1.49 - 2.36) 1997 Modelled IHME
1.93 (1.53 - 2.40) 1996 Modelled IHME
1.95 (1.55 - 2.46) 1995 Modelled IHME
1.96 (1.53 - 2.45) 1994 Modelled IHME
1.93 (1.46 - 2.49) 1993 Modelled IHME
1.9 (1.42 - 2.44) 1992 Modelled IHME
1.83 (1.38 - 2.33) 1991 Modelled IHME
1.87 (1.46 - 2.36) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
199 (137 - 279) 2019 Modelled IHME
195 (139 - 271) 2018 Modelled IHME
191 (140 - 258) 2017 Modelled IHME
187 (142 - 248) 2016 Modelled IHME
176 (137 - 232) 2015 Modelled IHME
167 (129 - 215) 2014 Modelled IHME
160 (124 - 205) 2013 Modelled IHME
149 (117 - 190) 2012 Modelled IHME
143 (111 - 184) 2011 Modelled IHME
138 (109 - 178) 2010 Modelled IHME
132 (105 - 170) 2009 Modelled IHME
124 (98 - 158) 2008 Modelled IHME
117 (93 - 148) 2007 Modelled IHME
114 (90 - 144) 2006 Modelled IHME
108 (85 - 137) 2005 Modelled IHME
105 (82 - 133) 2004 Modelled IHME
100 (78 - 125) 2003 Modelled IHME
96 (76 - 121) 2002 Modelled IHME
96 (76 - 121) 2001 Modelled IHME
96 (76 - 119) 2000 Modelled IHME
95 (75 - 120) 1999 Modelled IHME
93 (74 - 117) 1998 Modelled IHME
91 (72 - 114) 1997 Modelled IHME
91 (72 - 113) 1996 Modelled IHME
90 (71 - 113) 1995 Modelled IHME
88 (69 - 110) 1994 Modelled IHME
85 (64 - 109) 1993 Modelled IHME
81 (61 - 104) 1992 Modelled IHME
76 (57 - 97) 1991 Modelled IHME
76 (59 - 96) 1990 Modelled IHME
199 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
38 (28 - 47) 2019 Modelled IHME
38 (29 - 47) 2018 Modelled IHME
38 (29 - 48) 2017 Modelled IHME
38 (29 - 48) 2016 Modelled IHME
38 (29 - 47) 2015 Modelled IHME
38 (29 - 47) 2014 Modelled IHME
38 (29 - 47) 2013 Modelled IHME
38 (29 - 47) 2012 Modelled IHME
38 (29 - 47) 2011 Modelled IHME
38 (29 - 47) 2010 Modelled IHME
38 (29 - 47) 2009 Modelled IHME
38 (29 - 47) 2008 Modelled IHME
38 (29 - 47) 2007 Modelled IHME
38 (29 - 47) 2006 Modelled IHME
38 (29 - 48) 2005 Modelled IHME
38 (29 - 47) 2004 Modelled IHME
38 (29 - 47) 2003 Modelled IHME
38 (28 - 47) 2002 Modelled IHME
37 (28 - 46) 2001 Modelled IHME
37 (28 - 46) 2000 Modelled IHME
37 (28 - 46) 1999 Modelled IHME
37 (28 - 46) 1998 Modelled IHME
37 (28 - 46) 1997 Modelled IHME
37 (28 - 46) 1996 Modelled IHME
37 (28 - 46) 1995 Modelled IHME
37 (28 - 46) 1994 Modelled IHME
37 (28 - 45) 1993 Modelled IHME
37 (28 - 45) 1992 Modelled IHME
37 (28 - 45) 1991 Modelled IHME
37 (28 - 46) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
Source:
HBV elimination goal
Source:
Year of HBV elimination goal
2030
Source:
HBV testing policy
Pregnant women
Source:
HepB birth dose policy
Yes
Source:
Year of birth dose introduction
2017
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
Source:
HCV elimination goal
Source:
Year of HCV elimination goal
2030
Source:
HCV testing policy
Risk-based
Source:
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Overview

HBV elimination goal
Year of goal
2030
HCV elimination goal
Year of goal
2030

Prevalence (national)

Modelled

HBV (HBsAg+)
2.99 (%)
2019
(2.44 - 3.54(%))
IHME
HCV (RNA/cAg+)
1.87 (%)
2019
(1.5 - 2.34(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
118
2019
(79 - 170)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
199
2019
(137 - 279)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.14 (%)
2019, latest modelled
(0.10 - 0.19(%))
IHME

Prevalence PWID

HCV
0
, latest modelled

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Action plan

View all

Action plans

Resources